Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sergio Islas-Andrade

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
The American Journal of Clinical Nutrition|January 30, 2004
Effects of biotin on pyruvate carboxylase, acetyl-CoA carboxylase, propionyl-CoA carboxylase, and markers for glucose and lipid homeostasis in type 2 diabetic patients and nondiabetic subjectsArmida Báez-Saldaña, Iván Zendejas-Ruiz, Cristina Revilla-Monsalve, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 9, 2006
Biotin supplementation reduces plasma triacylglycerol and VLDL in type 2 diabetic patients and in nondiabetic subjects with hypertriglyceridemiaCristina Revilla-Monsalve, Iván Zendejas-Ruiz, Sergio Islas-Andrade, et al.
Pharmacology|April 25, 2003
Evaluation of the effects of nateglinide on postprandial glycemia in patients with type 2 diabetes mellitus: a multicenter, multinational, non-randomized, non-controlled Latin American studySergio Islas-Andrade, Maria Cristina Revilla-Monsalve, Evelyn Martínez de Hurtado, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|March 26, 2011
β-cell function is associated with metabolic syndrome in Mexican subjectsBlanca G Baez-Duarte, María Del Carmen Sánchez-Guillén, Ricardo Pérez-Fuentes, et al.
Revista Medica Del Instituto Mexicano Del Seguro Social|January 10, 2009
[Cardiovascular risk factors associated to abdominal obesity in apparently healthy subjects]Antonio González-Chávez, Octavio Amancio-Chassin, Sergio Islas-Andrade, et al.
Plos One|May 2, 2015
Association of HMOX1 and NQO1 Polymorphisms with Metabolic Syndrome ComponentsAngélica Martínez-Hernández, Emilio J Córdova, Oscar Rosillo-Salazar, et al.
Medicine, Health Care, and Philosophy|September 5, 2014
Novel ethical dilemmas arising in geriatric clinical practiceElisa Constanza Calleja-Sordo, Adalberto de Hoyos, Jorge Méndez-Jiménez, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|January 17, 2020
Low Serum Interleukin-6 Is a Differential Marker of Obesity-Related Metabolic Dysfunction in Women and MenLucia A Méndez-García, Miguel Cid-Soto, José A Aguayo-Guerrero, et al.
Plos One|August 1, 2017
Today´s medical self and the other: Challenges and evolving solutions for enhanced humanization and quality of carePerla Sueiras, Victoria Romano-Betech, Alejandro Vergil-Salgado, et al.
Journal of Immunology Research|June 1, 2018
High-Density Lipoprotein Reduction Differentially Modulates to Classical and Nonclassical Monocyte Subpopulations in Metabolic Syndrome Patients and in LPS-Stimulated Primary Human Monocytes <i>In Vitro</i>Johanna L Grün, Aaron N Manjarrez-Reyna, Angélica Y Gómez-Arauz, et al.
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
The American Journal of Clinical Nutrition|January 30, 2004
Effects of biotin on pyruvate carboxylase, acetyl-CoA carboxylase, propionyl-CoA carboxylase, and markers for glucose and lipid homeostasis in type 2 diabetic patients and nondiabetic subjectsArmida Báez-Saldaña, Iván Zendejas-Ruiz, Cristina Revilla-Monsalve, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 9, 2006
Biotin supplementation reduces plasma triacylglycerol and VLDL in type 2 diabetic patients and in nondiabetic subjects with hypertriglyceridemiaCristina Revilla-Monsalve, Iván Zendejas-Ruiz, Sergio Islas-Andrade, et al.
Pharmacology|April 25, 2003
Evaluation of the effects of nateglinide on postprandial glycemia in patients with type 2 diabetes mellitus: a multicenter, multinational, non-randomized, non-controlled Latin American studySergio Islas-Andrade, Maria Cristina Revilla-Monsalve, Evelyn Martínez de Hurtado, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|March 26, 2011
β-cell function is associated with metabolic syndrome in Mexican subjectsBlanca G Baez-Duarte, María Del Carmen Sánchez-Guillén, Ricardo Pérez-Fuentes, et al.
Revista Medica Del Instituto Mexicano Del Seguro Social|January 10, 2009
[Cardiovascular risk factors associated to abdominal obesity in apparently healthy subjects]Antonio González-Chávez, Octavio Amancio-Chassin, Sergio Islas-Andrade, et al.
Plos One|May 2, 2015
Association of HMOX1 and NQO1 Polymorphisms with Metabolic Syndrome ComponentsAngélica Martínez-Hernández, Emilio J Córdova, Oscar Rosillo-Salazar, et al.
Medicine, Health Care, and Philosophy|September 5, 2014
Novel ethical dilemmas arising in geriatric clinical practiceElisa Constanza Calleja-Sordo, Adalberto de Hoyos, Jorge Méndez-Jiménez, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|January 17, 2020
Low Serum Interleukin-6 Is a Differential Marker of Obesity-Related Metabolic Dysfunction in Women and MenLucia A Méndez-García, Miguel Cid-Soto, José A Aguayo-Guerrero, et al.
Plos One|August 1, 2017
Today´s medical self and the other: Challenges and evolving solutions for enhanced humanization and quality of carePerla Sueiras, Victoria Romano-Betech, Alejandro Vergil-Salgado, et al.
Journal of Immunology Research|June 1, 2018
High-Density Lipoprotein Reduction Differentially Modulates to Classical and Nonclassical Monocyte Subpopulations in Metabolic Syndrome Patients and in LPS-Stimulated Primary Human Monocytes <i>In Vitro</i>Johanna L Grün, Aaron N Manjarrez-Reyna, Angélica Y Gómez-Arauz, et al.
Pageof 5